Hing C. Wong

9.5k citations
130 papers · 6.6k · 2 hit papers · h-index 41

Impact in

  • Immunology top 0.5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Virology top 2%
    • HIV Research and Treatment

Papers in

    • Immune Cell Function and Interaction 54
    • T-cell and B-cell Immunology 24
    • Immunotherapy and Immune Responses 16
    • CAR-T cell therapy research 41
    • Cancer Immunotherapy and Biomarkers 15

Hing C. Wong

127 papers receiving 6.3k citations

Hing C. Wong's Hit Papers

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery 2018 · 567 citations
5670+7+14Years since publication100200300400500

Peers

Hing C. Wong
Comparison fields: 5 of 129
  • Immunology 2.7k
  • Virology 370
  • Oncology 1.8k
  • Biotechnology 371
  • Molecular Biology 2.3k
Replace Hugues Lortat‐Jacob with:
Hugues Lortat‐Jacob France
Gerrit Koopman Netherlands
Michael Bachmann Germany
Jun Hirabayashi Japan
Peter Van Endert France
Riccardo Cortese Italy
Marco Rusnati Italy
Bryan E. Roberts United States
Bruce A. Sullenger United States
Victor S. Goldmacher United States
Hing C. Wong relative to Hugues Lortat‐Jacob France Hugues Lortat‐Jacob's profile →
Citations per field
00.5×2×3.4×
Hugues Lortat‐Jacob · 1×
Citations per year

Countries citing papers authored by Hing C. Wong

Since Specialization
Citations

This map shows the geographic impact of Hing C. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hing C. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hing C. Wong more than expected).

Fields of papers citing papers by Hing C. Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hing C. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hing C. Wong. The network helps show where Hing C. Wong may publish in the future.

Co-authors

The 25 scholars most cited alongside Hing C. Wong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hing C. Wong Line = papers co-authored together Hing C. Wong links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sequestosome 1/p62 Is a Polyubiquitin Chain Binding Protein Involved in Ubiquitin Proteasome Degradation
Hit paper breakdown →
2004593
2
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Hit paper breakdown →
2018567
3 2008329
4 1998312
5 1990298
6 2017223
7 2015175
8 2011174
9 1983173
10 2013162
11 1985161
12 1986159
13 2018151
14 2016140
15 2000129
16 2009125
17 2002108
18 2017108
19 2017104
20 201587

About Hing C. Wong

Hing C. Wong is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 130 papers that have together received 6.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (54 papers), CAR-T cell therapy research (41 papers), T-cell and B-cell Immunology (24 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Immunology (2.7k citations), Virology (370 citations), Oncology (1.8k citations), Biotechnology (371 citations) and Molecular Biology (2.3k citations). Hing C. Wong has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Emily K. Jeng, Peter R. Rhode, H.R. Whiteley, H E Schnepf, N. Rama Krishna, Thangiah Geetha, Marie W. Wooten, M. Lamar Seibenhener, Jeganathan Ramesh Babu and Sui‐Yuan Chang. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Cancer Research, Blood and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact